gimli

GAUDIUMIVF stock AI analysis

GAUDIUMIVF Stock AI Analysis: Price, PE, 50DMA, Shareholding and Peers

GAUDIUM IVF N WOMEN H L is a small-cap stock in Healthcare. This Gimli page shows the latest available GAUDIUMIVF price, returns, 50DMA/200DMA trend, PE, ROE, ROCE, financials, shareholding pattern, and industry peers for Indian stock screening research.

Analyze with AI Open interactive GAUDIUMIVF stock page

Price

₹155.41

1W return

+16.49%

1M return

+42.95%

3M return

+50.53%

6M return

n/a

1Y return

n/a

Market cap

₹1,131.18 cr

46.19

7.43

ROE

+24.66%

ROCE

+29.28%

RSI

79.50

Turnover

₹4.23 cr

Why it can matter in screens

Momentum: GAUDIUMIVF is above 50DMA, below 200DMA; RSI is 79.50.
Returns: 1D +4.99%, 1W +16.49%, 1M +42.95%, 3M +50.53%, 1Y n/a.
Trend levels: 52W high ₹155.41, 52W low ₹70.67, off high +0.00%.
Liquidity: latest turnover is ₹4.23 cr; volume vs 20D is +1.08%.
Valuation/profitability: PE 46.19, PB 7.43, ROE +24.66%, ROCE +29.28%.
Growth: 3Y sales CAGR +33.11%, 3Y profit CAGR +21.86%.

Quick Answers

What is the latest GAUDIUMIVF stock price?

The latest stored price for GAUDIUMIVF is Rs 155.41 as of 2026-07-21.

Is GAUDIUMIVF above its 50DMA and 200DMA?

GAUDIUMIVF is above 50DMA, below 200DMA. The latest 50DMA is 115.40 and the latest 200DMA is n/a.

What are GAUDIUMIVF PE, ROE and ROCE?

GAUDIUMIVF has PE 46.19, ROE +24.66%, and ROCE +29.28% in Gimli's latest available snapshot.

How has GAUDIUMIVF performed recently?

GAUDIUMIVF has returned +42.95% over 1 month, +50.53% over 3 months, and n/a over 12 months in the latest stored data.

Is this stock page investment advice?

No. This page is a data snapshot for screening and research. It is not buy, sell, legal, tax, or investment advice.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-03-31	30.35 cr	12.35 cr	8.36 cr	1.34
2025-12-31	24.51 cr	6.65 cr	3.63 cr	0.50
2025-09-30	31.88 cr	13.91 cr	9.38 cr	1.53
2025-03-31	26.92 cr	8.96 cr	6.46 cr	0.89
2024-12-31	14.42 cr	5.66 cr	3.40 cr	0.47

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	104.36 cr	38.24 cr	24.49 cr	nan
2025-03-31	70.72 cr	28.87 cr	19.18 cr	2.63
2024-03-31	47.89 cr	19.54 cr	10.32 cr	1.42
2023-03-31	44.24 cr	20.09 cr	13.53 cr	1.86
2022-03-31	n/a	n/a	n/a	1.11

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	193.10 cr	8.79 cr	24.57 cr	152.30 cr
2025-03-31	88.51 cr	7.21 cr	20.61 cr	46.30 cr
2024-03-31	51.01 cr	11.86 cr	17.40 cr	26.99 cr
2023-03-31	36.63 cr	15.06 cr	11.55 cr	22.73 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	7.25 cr	0.53 cr	n/a
2025-03-31	8.72 cr	-0.16 cr	n/a
2024-03-31	3.44 cr	0.65 cr	n/a
2023-03-31	23.85 cr	8.60 cr	n/a
2022-03-31	n/a	n/a	n/a

Shareholding Trend

Period	Promoter	FII/FPI	DII	MF	Retail	Pledge
2026-06-30	+71.29%	+3.02%	+2.22%	+0.00%	+23.47%	+0.00%
2026-03-31	+71.29%	+6.70%	+2.62%	+0.00%	+19.39%	+0.00%
2026-02-26	+71.29%	+9.24%	+5.11%	+0.00%	+14.36%	+0.00%

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	470,725.53 cr	40.938102	+14.71%	+15.93%
DIVISLAB	DIVI S LABORATORIES LTD	194,588.48 cr	75.774332	+16.19%	+9.60%
TORNTPHARM	TORRENT PHARMACEUTICALS L	170,600.17 cr	78.872017	+17.18%	+43.04%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	128,349.41 cr	65.537894	+21.03%	+23.05%
CIPLA	CIPLA LTD	115,717.42 cr	29.815932	+11.79%	-2.81%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	115,022.61 cr	22.938459	+17.93%	+17.85%
LUPIN	LUPIN LIMITED	114,980.65 cr	21.532280	+26.83%	+30.91%
MAXHEALTH	MAX HEALTHCARE INS LTD	107,095.75 cr	74.247785	+14.33%	-9.67%

Try these prompts

Analyze GAUDIUM IVF N WOMEN H L with valuation, momentum and industry peers
Compare GAUDIUMIVF with other Healthcare stocks
Show small-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-07-21. Not investment advice.